GSA Capital Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-262,544
| Closed | -$394K | – | 2119 |
|
|
2018
Q1 | $394K | Sell |
262,544
-131,500
| -33% | -$197K | 0.02% | 1184 |
|
|
2017
Q4 | $560K | Sell |
394,044
-74,751
| -16% | -$106K | 0.03% | 885 |
|
|
2017
Q3 | $1.07M | Sell |
468,795
-73,000
| -13% | -$167K | 0.07% | 481 |
|
|
2017
Q2 | $731K | Buy |
541,795
+254,400
| +89% | +$343K | 0.05% | 764 |
|
|
2017
Q1 | $615K | Buy |
287,395
+115,400
| +67% | +$247K | 0.03% | 972 |
|
|
2016
Q4 | $758K | Sell |
171,995
-95,200
| -36% | -$420K | 0.05% | 721 |
|
|
2016
Q3 | $1.3M | Buy |
267,195
+174,800
| +189% | +$848K | 0.07% | 461 |
|
|
2016
Q2 | $305K | Buy |
92,395
+33,100
| +56% | +$109K | 0.02% | 1374 |
|
|
2016
Q1 | $210K | Buy |
+59,295
| New | +$210K | 0.01% | 1469 |
|